BioLife Solutions to build second GMP production facility
The additional space will be used to the build a second GMP manufacturing clean room suite and space for team members. BioLife Solutions chief executive officer Mike Rice
The US Food and Drug Administration (FDA) has granted priority review to Roche’s supplemental biologics licence application (sBLA) for Gazyva/Gazyvaro (obinutuzumab) to treat adults with primary membranous nephropathy (pMN).